COSMOS Pharmaceutical Corporation (JP:3349)
:3349
Want to see JP:3349 full AI Analyst Report?
3349 Stock Chart & Stats
¥6699.00
¥109.00(1.60%)
At close: 4:00 PM EST
¥6699.00
¥109.00(1.60%)
Day’s Range― - ―
52-Week Range¥5,615.00 - ¥10,045.00
Previous CloseN/A
Volume659.40K
Average Volume (3M)399.89K
Market Cap
¥478.55B
Enterprise Value¥496.37B
Total Cash (Recent Filing)¥57.04B
Total Debt (Recent Filing)¥49.96B
Price to Earnings (P/E)15.2
Beta-0.22
Next Earnings
Jul 13, 2026EPS Estimate
117.37Next Dividend Ex-DateN/A
Dividend Yield0.93%
Share Statistics
EPS (TTM)390.85
Shares Outstanding80,001,600
10 Day Avg. Volume586,980
30 Day Avg. Volume399,893
Financial Highlights & Ratios
PEG Ratio0.85
Price to Book (P/B)2.72
Price to Sales (P/S)0.69
P/FCF Ratio-814.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)418.47
Revenue Forecast (FY)¥1.18T
Bulls Say, Bears Say
Bulls Say
Revenue GrowthConsistent multi-year revenue growth indicates durable market demand for the Cosmos drugstore model and expanding consumer adoption. Over 2-6 months this supports stable top-line momentum, improves negotiating leverage with suppliers, and underpins reinvestment in stores and merchandising to sustain growth.
Balance Sheet StrengthA low debt-to-equity ratio and robust equity base give the company financial flexibility to fund expansion, absorb shocks, and pursue opportunistic investments without compromising solvency. This structural strength supports long-term stability and preserves strategic optionality.
Operating Cash GenerationSustained operating cash flow shows the retail business converts sales into recurring cash, supporting day-to-day liquidity and working capital needs. Over the medium term this cash generation can fund inventory, store operations and targeted capex if management improves capital spending timing.
Bears Say
Negative Free Cash FlowPersistent negative free cash flow means reported profits are not fully converting into surplus cash available for debt reduction, dividends or growth capex. Over months this can force reliance on external funding or constrain strategic investments, weakening financial resilience.
Rising Total DebtAlthough current leverage is low, a trend of rising total debt reduces future financial flexibility and raises servicing obligations. If debt continues upward while free cash flow remains negative, interest costs and refinancing risk could pressure margins and strategic choices.
Margin PressureA recent dip in EBIT margin signals emerging cost or pricing pressures in a competitive drugstore market. If sustained, margin compression would reduce operating profitability and limit the company’s ability to fund investments or absorb higher interest costs, impacting long-term earnings quality.
COSMOS Pharmaceutical Corporation News
3349 FAQ
What was COSMOS Pharmaceutical Corporation’s price range in the past 12 months?
COSMOS Pharmaceutical Corporation lowest stock price was ¥5615.00 and its highest was ¥10045.00 in the past 12 months.
What is COSMOS Pharmaceutical Corporation’s market cap?
COSMOS Pharmaceutical Corporation’s market cap is ¥478.55B.
When is COSMOS Pharmaceutical Corporation’s upcoming earnings report date?
COSMOS Pharmaceutical Corporation’s upcoming earnings report date is Jul 13, 2026 which is in 33 days.
How were COSMOS Pharmaceutical Corporation’s earnings last quarter?
COSMOS Pharmaceutical Corporation released its earnings results on Apr 13, 2026. The company reported ¥102.19 earnings per share for the quarter, beating the consensus estimate of ¥100.689 by ¥1.501.
Is COSMOS Pharmaceutical Corporation overvalued?
According to Wall Street analysts COSMOS Pharmaceutical Corporation’s price is currently Overvalued.
Does COSMOS Pharmaceutical Corporation pay dividends?
COSMOS Pharmaceutical Corporation pays a Semiannually dividend of ¥37.5 which represents an annual dividend yield of 0.93%. See more information on COSMOS Pharmaceutical Corporation dividends here
What is COSMOS Pharmaceutical Corporation’s EPS estimate?
COSMOS Pharmaceutical Corporation’s EPS estimate is 117.37.
How many shares outstanding does COSMOS Pharmaceutical Corporation have?
COSMOS Pharmaceutical Corporation has 80,001,600 shares outstanding.
What happened to COSMOS Pharmaceutical Corporation’s price movement after its last earnings report?
COSMOS Pharmaceutical Corporation reported an EPS of ¥102.19 in its last earnings report, beating expectations of ¥100.689. Following the earnings report the stock price went down -1.122%.
Which hedge fund is a major shareholder of COSMOS Pharmaceutical Corporation?
Currently, no hedge funds are holding shares in JP:3349
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
COSMOS Pharmaceutical Corporation
COSMOS Pharmaceutical Corporation manages an extensive network of drugstores throughout Japan. The company operates a significant 1,130 retail locations, strategically positioned across the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. Established in 1983, its primary office is situated in Fukuoka, Japan.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
Create SD Holdings Co., Ltd.
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Options Prices
Currently, No data available
---